User profiles for "author:Frederic Kridelka"
 | Frederic KRIDELKAProfesseur Gynécologie Obstétrique, Université de LIège Verified email at kridelka.com Cited by 2920 |
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
I Vergote, A Gonzalez-Martin, D Lorusso… - The Lancet …, 2022 - thelancet.com
Summary The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on
Clinical Research was held virtually in October, 2021, following published consensus …
Clinical Research was held virtually in October, 2021, following published consensus …
[HTML][HTML] The pre-metastatic niche in lymph nodes: formation and characteristics
L Gillot, L Baudin, L Rouaud, F Kridelka… - Cellular and Molecular …, 2021 - Springer
Lymph node metastasis is a crucial prognostic parameter in many different types of cancers
and a gateway for further dissemination to distant organs. Prior to metastatic dissemination …
and a gateway for further dissemination to distant organs. Prior to metastatic dissemination …
[HTML][HTML] Recurrent or primary metastatic cervical cancer: current and future treatments
C Gennigens, G Jerusalem, L Lapaille, M De Cuypere… - ESMO open, 2022 - Elsevier
Despite screening programs for early detection and the approval of human papillomavirus
vaccines, around 6% of women with cervical cancer (CC) are discovered with primary …
vaccines, around 6% of women with cervical cancer (CC) are discovered with primary …
[HTML][HTML] Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic-FRANCOGYN group for the CNGOF
C Akladios, H Azais, M Ballester, S Bendifallah… - Journal of gynecology …, 2020 - Elsevier
Introduction In the context of the COVID-19 pandemic, specific recommendations are
required for the management of patients with gynecologic cancer. Materials and method The …
required for the management of patients with gynecologic cancer. Materials and method The …
Contribution of whole-body 18FDG PET imaging in the management of cervical cancer
T Belhocine, A Thille, V Fridman, A Albert, L Seidel… - Gynecologic …, 2002 - Elsevier
Objective. The objective of this study was to assess the contribution of [18F] fluoro-2-deoxy-d-
glucose positron emission tomography (18FDG PET) imaging in the management of cervical …
glucose positron emission tomography (18FDG PET) imaging in the management of cervical …
Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase
B Detry, C Erpicum, J Paupert, S Blacher… - Blood, The Journal …, 2012 - ashpublications.org
Lymphatic dysfunctions are associated with several human diseases, including
lymphedema and metastatic spread of cancer. Although it is well recognized that lymphatic …
lymphedema and metastatic spread of cancer. Although it is well recognized that lymphatic …
[HTML][HTML] A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma
B Léonard, F Kridelka, K Delbecque, F Goffin… - BioMed research …, 2014 - hindawi.com
Condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma are three
relatively frequent vulvar lesions. Condyloma acuminatum is induced by low risk genotypes …
relatively frequent vulvar lesions. Condyloma acuminatum is induced by low risk genotypes …
[HTML][HTML] [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation
M Ferreira, P Lovinfosse, J Hermesse… - European Journal of …, 2021 - Springer
Purpose To test the performances of native and tumour to liver ratio (TLR) radiomic features
extracted from pre-treatment 2-[18 F] fluoro-2-deoxy-D-glucose ([18 F] FDG) PET/CT and …
extracted from pre-treatment 2-[18 F] fluoro-2-deoxy-D-glucose ([18 F] FDG) PET/CT and …
Optimal treatment in locally advanced cervical cancer
C Gennigens, M De Cuypere, J Hermesse… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Locally advanced cervical cancer (LACC)(International Federation of
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …
Randomized phase III study comparing neoadjuvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994
GG Kenter, S Greggi, I Vergote… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE This multicenter trial by the European Organisation for Research and Treatment
of Cancer Gynecological Cancer Group was motivated by conflicting evidence on the value …
of Cancer Gynecological Cancer Group was motivated by conflicting evidence on the value …